drugset / Trial / NCT03684772
Topical Ionic Contra-Viral Therapy in Actinic Keratosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To explore the pharmacodynamics and evaluate safety, tolerability and clinical efficacy of ICVT comprised of digoxin and furosemide (dual agent), digoxin (single agent), furosemide (single agent) in patients with AK.
Timeline
- Start
- 2018-10-22
- Primary completion
- 2019-09
- Completion
- 2019-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Digoxin | Other / unclassified | 0.125 % | Topical |
| Subject | Furosemide | Other / unclassified | 0.125 % | Topical |